QA Operations Internship: Vaccine Manufacturing (Polytechnic)

GSK; Singapore; On-site; SGD 17,000 - 23,000; Full time

Job summary

GSK invites students to join the Vaccines Business Area Internship (2027) in Singapore. You will be enrolled as a full-time, credit-bearing intern from March 2027 to August 2027, gaining hands-on experience in QA operations, batch records, and improvement projects under a diverse, cross-functional team.

You will develop skills in documentation, data integrity, GMP/QA practices, and professional communication while contributing to real quality assurance activities in a global biopharma

Qualifications

• Enrolled in a Singapore polytechnic for the duration of the internship.
• Full-time credit-bearing internship.
• Fluent in written and spoken English.
• Proficient in MS Word and MS Excel.
• Interest in vaccines manufacturing.

Responsibilities

• Perform annual reconciliation of processes (quality tag out, approved supplier listing).
• Scan and archive Batch Records.
• Perform QA Gemba.
• Maintain trackers (QI tracker, checklist review tracker, QTO tracker).
• Lead quality improvement projects (Kaizens).
• Develop training guide for QA GMP/ Batch Release Intern & induction programme.

Skills

Data Integrity

Detail-Oriented

Digital Fluency

GxP Regulations

Lean Management

Pharmaceutical Regulatory Compliance

Problem Solving

Quality Assurance (QA)

Risk Awareness

Technical Writing

Education

Diploma in Chemical & Biomedical Engineering or Pharmaceutical Science

Tools

MS Word

MS Excel

Job description

GSK invites students to join the Vaccines Business Area Internship (2027) in Singapore. You will be enrolled as a full-time, credit-bearing intern from March 2027 to August 2027, gaining hands-on experience in QA operations, batch records, and improvement projects under a diverse, cross-functional team.

You will develop skills in documentation, data integrity, GMP/QA practices, and professional communication while contributing to real quality assurance activities in a global biopharma